Skip to main content
TipRanks
Go Ultimate75% OFF

Community Health (CYH) AI Stock Analysis

429 Followers
CYH

Community Health

(NYSE:CYH)

Select Model
Rating:44Neutral
Price Target:$2.00â–¼(-0.99% Downside)
Action:reiterated
Date:11/10/26

CYH scores low primarily due to weak financial performance—especially negative equity and leverage-driven balance-sheet risk—alongside volatile profitability and inconsistent free cash flow. Technicals also remain bearish with the price below key moving averages and negative MACD. Valuation is a partial offset with a low P/E, but the latest earnings call featured reduced guidance and continued payer-mix and cost headwinds that limit near-term confidence.

Positive Factors
Same-store volume growthUnderlying volume growth shows continued demand across hospitals, clinics, and imaging despite portfolio changes. Broader patient activity can support revenue resilience, improve utilization of fixed facilities, and provide a foundation for longer-term growth if payer mix and procedure conversion improve.
Negative Factors
Stressed balance sheetPersistent negative equity and substantial debt leave limited financial flexibility and make the capital structure vulnerable to operating setbacks. High leverage can constrain investment, increase sensitivity to earnings declines, and reduce the company’s ability to absorb reimbursement or volume pressure.

Community Health Key Performance Indicators (KPIs)

Revenue by SourceBreaks down where the company earns money—Medicare, Medicaid, commercial insurers, self-pay, and services like outpatient or ancillary care. A heavy reliance on lower-paying government programs or one dominant payer raises reimbursement and policy risk, while a diversified mix with higher-margin services supports revenue stability and profit potential.

0.00%20.00%40.00%60.00%Mar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

The revenue mix has shifted toward government payors: a reporting-driven emergence of Medicare Managed Care (which explains the late‑2022 drop in the broad Managed Care category) plus a steady rise in Medicaid share, while traditional Medicare has declined. That secular shift toward lower‑margin government and growing self‑pay volumes helps explain falling revenue per admission and margin pressure; it clarifies why management is leaning on state‑directed payment wins and aggressive cost controls to sustain EBITDA.

Data provided by:The Fly

Community Health (CYH) vs. SPDR S&P 500 ETF (SPY)

-40%-30%-20%-10%0%10%20%30%CYH-35.26%SPY+13.46%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$284.87M
Dividend Yield
―
Average Volume (3M)
1.54M
Price to Earnings (P/E)
7.6
Beta (1Y)
1.73
Revenue Growth
-7.84%
EPS Growth
-88.93%
Country
US
Employees
50,500
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Community Health Business Overview & Revenue Model

Company Description

Community Health Systems, Inc. (CYH) operates as a major healthcare provider across the United States, focusing on the ownership, leasing, and management of general acute care hospitals. The organization offers a comprehensive array of medical servic...

How the Company Makes Money

CYH primarily makes money by providing healthcare services and receiving reimbursement from third-party payors and patients. The largest revenue stream is net patient service revenue generated when its hospitals and related facilities deliver inpatie...

Community Health Earnings Call Summary

Earnings Call Date:Oct 28, 2026(Q3-2026)|% Change Since:-24.06%|Next Earnings Date:Feb 17, 2027
Earnings Call SentimentNegative

The call included meaningful operational positives, including strong clinical quality, lower workforce turnover, growing clinic and imaging volumes, cost savings, improved cash flow, debt reduction, and continued investment in ambulatory capacity. However, the financial tone was pressured by a 7% core adjusted EBITDA decline, a lower EBITDA margin, unfavorable uninsured and commercial elective mix, elevated medical specialty costs, higher leverage, slower payer payments, declining self-pay collections, and reduced full-year guidance. Management also paused its medium-term targets and highlighted several 2027 uncertainties. Overall, the negative financial trends and outlook revisions outweighed the operational achievements.

Positive Updates

Improved Clinical Quality Performance
CHS further reduced severe sepsis and septic shock mortality rates and hospital-acquired infection metrics in the third quarter, continuing to outperform national benchmarks. The company also cited strong Leapfrog safety grades across its network.

Negative Updates

Third-Quarter Results Fell Below Internal Expectations
Third-quarter adjusted EBITDA was $280 million, with a 10.2% margin versus 12.2% in the prior-year period. Excluding divestitures and out-of-period items from the prior-year results, adjusted EBITDA reflected an approximate 7% core decline year over year.

Company Guidance

For full year 2026, net revenue is now expected to be $11.3 billion-$11.5 billion, adjusted EBITDA is expected to be $1.225 billion-$1.275 billion, or a 6.5% reduction at the midpoint, and cash flow from operations is expected to be $100 million-$300 million; fourth-quarter cash flow from operations is expected to be $85 million-$185 million, while capital expenditures are still expected to be between $350 million-$400 million. Year one awards under the Rural Health Transformation Program are expected to be $25 million-$30 million, with income recognized over a multiple year period starting in 2027. The 2027 outlook includes an out-of-period state-directed payment benefit of about a $15 million-$20 million net benefit in 2026 that won't repeat, a modest positive impact from Rural Health Transformation Program funds, another quarter of higher uninsured volumes, a potential moderate headwind in the fourth quarter of 2027 from the OBBBA funding cut to provider taxes, and medical specialties expected to continue to grow well above inflation next year. The full-year 2026 HIX disenrollment and movement to self-pay impact is now expected to be $80 million-$90 million, with the fourth quarter expected to be maybe $25 million-$30 million, and actions taken to date have a future benefit of something in that $100 million range, plus.

Community Health Financial Statement Overview

Summary

Weak overall financial profile driven by balance-sheet stress (persistent negative equity and historically heavy leverage). Operating results and margins are volatile with losses in multiple recent periods and a return to losses in TTM, while free cash flow is frequently negative despite periods of positive operating cash flow.

Income Statement

34Negative

Balance Sheet

18Very Negative

Cash Flow

29Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue11.65B12.48B12.63B12.49B12.21B12.37B
Gross Profit8.15B1.49B5.27B5.08B4.91B5.08B
EBITDA1.69B2.02B1.33B1.38B1.25B1.82B
Net Income36.00M509.00M-516.00M-133.00M46.00M230.00M
Balance Sheet
Total Assets12.11B13.20B14.05B14.46B14.67B15.22B
Cash, Cash Equivalents and Short-Term Investments155.00M260.00M37.00M38.00M118.00M507.00M
Total Debt10.21B11.58B12.10B12.17B12.39B12.82B
Total Liabilities13.04B14.04B15.37B15.28B15.40B16.03B
Stockholders Equity-1.49B-1.39B-1.91B-1.39B-1.37B-1.37B
Cash Flow
Free Cash Flow-122.00M208.00M120.00M-257.00M-115.00M-600.00M
Operating Cash Flow211.00M543.00M480.00M210.00M300.00M-131.00M
Investing Cash Flow1.03B847.00M-277.00M-22.00M-251.00M-543.00M
Financing Cash Flow-1.21B-1.17B-204.00M-268.00M-438.00M-495.00M

Community Health Technical Analysis

Technical Analysis SentimentNegative
Last Price2.02

Price Trends

50DMA2.69Negative
100DMA2.89Negative
200DMA2.97Negative

Market Momentum

MACD-0.18Positive
RSI33.03Neutral
STOCH19.51Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CYH, the sentiment is Negative. The current price of 2.02 is below the 20-day moving average (MA) of 2.41, below the 50-day MA of 2.69, and below the 200-day MA of 2.97, indicating a bearish trend. The MACD of -0.18 indicates Positive momentum. The RSI at 33.03 is Neutral, neither overbought nor oversold. The STOCH value of 19.51 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CYH.

Community Health Risk Analysis

Community Health disclosed 74 risk factors in its most recent earnings report. Community Health reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.Recent U.S. Supreme Court decisions affecting the review of federal agency actions could adversely impact our business and operations.Q3, 2024
2.Recent U.S. Supreme Court decisions affecting the review of federal agency actions could adversely impact our business and operations.Q2, 2024
3.If the redesign and consolidation of key business functions, including through the implementation of a core enterprise resource planning system, or ERP, does not proceed as expected or is not completed successfully, our business and financial results may be adversely impacted.Q4, 2023

Community Health Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

CYH against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
ADUSADUS83Outperform$2.27B20.389.81%―11.53%27.72%
EHCEHC70Outperform$13.53B21.4625.17%0.57%9.36%20.78%
NHCNHC68Neutral$3.22B27.8510.41%1.27%5.71%12.44%
AVAHAVAH65Neutral$2.54B7.94115.53%―16.84%280.13%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
CYHCYH44Neutral$284.87M7.57-2.51%―-7.84%-88.93%

* Healthcare Sector Average

Performance Comparison

0%50%CYHADUSEHCNHCAVAHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CYH and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CYHCommunity Health Systems2.02-0.92-31.29%
ADUSAddus HomeCare Corporation121.5611.4910.44%
EHCEncompass Health137.8825.9223.15%
NHCNational Healthcare205.7780.2963.98%
AVAHAveanna Healthcare Holdings Inc11.653.3540.36%

Community Health Corporate Events

Private Placements and Financing

Community Health Announces Private Debt Exchange Offer

Negative
Nov 10, 2026

On November 9, 2026, Community Health Systems announced that its wholly owned subsidiary intended to commence a private offer to exchange approximately $1.244 billion of 6.875% Junior-Priority Secured Notes due 2029 for 10.250% Senior Secured Notes d...

Business Operations and StrategyFinancial DisclosuresM&A Transactions

Community Health Systems Reports Third-Quarter Loss, Portfolio Shifts

Negative
Oct 28, 2026

Community Health Systems, Inc. is a U.S. hospital operator that owns and manages acute care facilities and related healthcare services, with a focus on same-store performance across its portfolio. The company has been actively reshaping its footprint...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 10, 2026